The biotech aims to complete rolling submissions with regulators in the U.K. and Australia in the first half of 2023.
Vaxxinity eyes global COVID-19 vaccine market with ‘next-gen’ booster
The biotech aims to complete rolling submissions with regulators in the U.K. and Australia in the first half of 2023.
